REGN – regeneron pharmaceuticals, inc. (US:NASDAQ)

News

2 Biotech Giants to Buy in 2026 [Yahoo! Finance]
Jim Cramer Says “I Should Have Pulled the Trigger on Regeneron” [Yahoo! Finance]
These 5 New York companies are among America's best employers [USA TODAY]
Regeneron Pharmaceuticals (REGN) had its price target raised by Royal Bank Of Canada from $745.00 to $765.00. They now have a "sector perform" rating on the stock.
Regeneron's Dupixent Win And Rare Disease Push Reshape Risk Reward Profile [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com